Home Tags Moderna
The first study of a potential coronavirus vaccine will soon start recruiting healthy volunteers in Georgia at Emory University
The NIH, which is running this first study of a coronavirus vaccine candidate, will recruit volunteers in Georgia as well as Washington state.
The first trial of a potential coronavirus vaccine just started in Washington state. It will take at least a year to know if the vaccine works.
While research has moved at historic speed to reach this point, it will take at least a year of clinical testing to determine if the vaccine works.
The first clinical trial for a potential coronavirus vaccine is now recruiting volunteers and offering up to $1,100 in compensation.
The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time
We got the full story of how Moderna went from the genetic code of the virus to shipping a vaccine in 42 days.
‘Crazy hours, short nights’: The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time
The potential vaccine still needs at least 12 to 18 months of testing in people to determine if it's safe and works to prevent the coronavirus.
The CEO of the buzzy biotech that’s working on a potential coronavirus vaccine just pledged he won’t set a high price for the shot
Moderna CEO Stephane Bancel said the company will be "extremely thoughtful and sensitive" in determining a price if its experimental vaccine works.
We don’t have any good treatments for the novel coronavirus right now, but scientists are racing to change that
Roughly 80% of coronavirus cases are mild, but others can be a lot more serious. Here's how doctors are trying to treat COVID-19.
Dispensed: Coronavirus spreads, drugmakers scramble to respond, and the latest magic mushroom startups
Welcome to Dispensed, Business Insider's weekly healthcare newsletter. This week, we're focused on the spreading coronavirus outbreak.
A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked...
Moderna has gained the most of the three since Friday's close, jumping 60% after submitting the first coronavirus vaccine for human trials.
Coronavirus vaccine developer Moderna soared 30% as US stocks suffered their worst stretch in years. Here are the 10 investors that benefited most ...
Moderna shares spiked after the company announced it shipped the first coronavirus vaccine for human testing in the US.